
SARS-CoV-2-IN-39
CAS No. 2882823-03-0
SARS-CoV-2-IN-39( —— )
Catalog No. M36928 CAS No. 2882823-03-0
SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 73 | Get Quote |
![]() ![]() |
5MG | 113 | Get Quote |
![]() ![]() |
10MG | 166 | Get Quote |
![]() ![]() |
25MG | 271 | Get Quote |
![]() ![]() |
50MG | 408 | Get Quote |
![]() ![]() |
100MG | 588 | Get Quote |
![]() ![]() |
500MG | 1215 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSARS-CoV-2-IN-39
-
NoteResearch use only, not for human use.
-
Brief DescriptionSARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1.
-
DescriptionSARS-CoV-2-IN-39 (compound 21) is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 against SARS-CoV-2 by inhibiting of SKP2 protein and stabilizing BECN1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetAntiviral
-
RecptorSARS-CoV | Antiviral
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2882823-03-0
-
Formula Weight349.66
-
Molecular FormulaC14H8ClF4NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NC1=CC=C(OC(F)(F)F)C=C1)(=O)C2=C(O)C=C(F)C(Cl)=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rui Li, et al. Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2. Eur J Med Chem. 2023 May 5;253:115320. ?
molnova catalog



related products
-
YM-53403
YM-53403 is an antiviral activity that effectively inhibits the replication of RSV strains belonging to subgroup A and subgroup B. It can be used to treat respiratory syncytial virus infections.
-
cis-Vaccenic acid
cis-Vaccenic acid (Asclepic acid) is the antiviral extract from Rhodopseudomonas capsulate and the predominant active component of Rhodopseudomonas capsulate. cis-Vaccenic acid acts a potential fetal hemoglobin inducer.
-
DC 07090
DC 07090 is a human enterovirus 71 3C protease inhibitor with antiviral activity for the study of nucleic acid virus infections.